Clinical Trials in New York

Showing 4281-4300 of 22,668 trials

Hand Transplantation

NCT02476838

The purpose of this study is to see if an investigational surgery that transfers tissue from a non-living donor to living individual will help restore greater function, appearance, and sensation to the hand and forearm areas of individuals who have suffered traumatic injury to the hand and forearm. This procedure is called a hand allotransplantation or "hand transplant". This study will also collect data on how patients do during and after having a hand transplant from a nonliving donor. Recovery and outcomes will be observed through clinical exams, x-rays, blood and tissue tests, and other associated evaluations at all follow up visits.

Amputation

NYU Langone Health100 participantsStarted Jun 2015

New York, New York, United States

Active Not RecruitingPhase 2< 1 mile

A Phase 2a Proof-of-Concept Trial of Bempikibart (ADX-914) for the Treatment of Severe Alopecia Areata (SIGNAL-AA)

NCT06018428

Part A is a randomized, double-blind, placebo-controlled, multi-center Proof-of-Concept (POC) Trial in subjects with severe Alopecia Areata. All participants in Part A have completed participation. Part B is a multicenter, open-label study to assess the efficacy, safety, and tolerability of bempikibart (ADX-914) in participants with severe Alopecia Areata.

Alopecia Areata

Q32 Bio Inc.75 participantsStarted Sep 2023

Scottsdale, Arizona, United States • Fayetteville, Arkansas, United States • Hot Springs, Arkansas, United States +30 more locations

Hand Transplantation

A Phase 2a Proof-of-Concept Trial of Bempikibart (ADX-914) for the Treatment of Severe Alopecia Areata (SIGNAL-AA)

Find Trials by Condition in New York

To Evaluate Safety and Tolerability of the Fixed- Dose Combination of Obeticholic Acid and Bezafibrate

Enhanced Nutritional Optimization in LVAD Trial

Efficacy and Safety of Encaleret Compared to Standard of Care in Participants With ADH1

Cognitive Training and Neuroplasticity in Mild Cognitive Impairment: COGIT-2 Trial

Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer

Efficacy of the I-CARE Digital Health Intervention

COVID-19 Survivorship Registry

Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib.

Carboplatin and Paclitaxel With or Without Ramucirumab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Thymic Cancer That Cannot Be Removed by Surgery

Study to Assess the Efficacy & Safety of KHK4951 in Patients With Diabetic Macular Edema

Ertugliflozin Type 2 Diabetes Mellitus (T2DM) Pediatric Study (MK-8835/PF-04971729) (MK-8835-059)

Studies of Brain and Body Interaction

Post-Market Study to Assess iTind Safety in Comparison to UroLift

Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC).

SARC044: A Phase II Trial of Bezuclastinib in Combination With Sunitinib in Patients With GIST

Metabolomics of Obstructive Sleep Apnea

Multicenter Assessment of the Pancreas in Type 1 Diabetes

Phase 3, Randomized, Placebo-Controlled Study of Tinlarebant to Explore Safety and Efficacy in Adolescent Stargardt Disease